Intranasal ketamine is approved for use in pediatric sedation (physician-administered) and will primarily be used in the pediatric ED. The injectable product is used and administered via an atomizer.

Ketamine was approved for use by ED physicians for analgesia at doses of 0.2-0.5 mg/kg IV push (max 50 mg). Medication to be administered IV push by a physician.

ICU Ketamine for Sedation (ketamine for continuous ICU sedation) PowerPlan is restricted to Critical Care/Pulmonology/Intensivists/Trauma.

Reviewed: February 28, 2012 (Intranasal Ketamine) and 23 June 2015 (ED use of ketamine IVP for analgesia), and Jan 2021 (Ketamine ICU sedation)

• Micromedex
• UpToDate
• Lippincott Advisor